Use of Monoterpenes as Potential Therapeutics in Diabetes Mellitus: A Prospective Review
Table 5
Patents related to the use of monoterpenes in diabetes therapy.
Title
IPC
Year
Country
Patent purpose
Reference
Compositions of monoterpenoids for stimulating the immune system
A61K31/045
2012
France
Pharmaceutical composition containing monoterpenoids, intended for the treatment of immune disorders, associated with conditions such as diabetes, alcohol or drug abuse, or obesity
Extract of Toona sinensis from supercritical fluid extraction for treating diabetes and metabolic diseases, the preparation method and the use thereof
A61K36/58
2011
China
Toona sinensis extract should be used as a food supplement or in pharmaceutical compositions. It can lower blood sugar levels, promote lipid breakdown, and treat metabolic disorders.
Synergistic composition of (−)-hydroxycitric acid with monoterpene and a method to enhance satiety
A61K31/194
2011
EUA
Pharmaceutical or synergistic food composition comprising (−)-hydroxycitric acid, its salts, amides, and esters together with monoterpenes to increase satiety and help control obesity and prevent diabetes
Use of monoterpenes compound in preparation of medicine against diabetes mellitus
A61K31/015
2006
China
An application of the monoterpene compounds, especially d-limonene, in the preparation of the drug in oily liquid form for the treatment of diabetes is disclosed
Nutritional and therapeutical preparations having antioxidant activity
A23D7/00
2004
EUA
Pharmaceutical and dietary compositions for the treatment and prevention of aging processes and related conditions, among them diabetes, comprising a lipid blend rich in polyunsaturated fatty acids and vitamins, in combination or not with monoterpenes and/or sesquiterpenes
